Dane Finley

The news: The Drug-price Transparency for Consumers Act of 2025 was recently reintroduced at the beginning of Congress by Senators Dick Durbin (D., Ill.) and Chuck Grassley (R., Ia.). Here’s what the Act entails: The legislation requires the inclusion of a drug’s list price or wholesale acquisition cost in all direct-to-consumer (D2C) advertisements. For context, the list price represents the price of a prescription drug set by a manufacturer before any rebates or discounts.

The news: UnitedHealth Group’s shares fell nearly 5% as of the time of writing after the healthcare giant reported mixed earnings results for Q4 2024. Profits were $5.5 billion for the quarter and $14.4 billion for the year. Key earnings stats: The company’s quarterly revenues grew about 7% year-over-year to $100.81 billion—missing the Zacks consensus estimate of $102.25 billion.

The news: UPS entered the healthcare logistics space in stealth mode to help offset stagnating revenues in its core delivery business, according to Transport Topics. Dubbed UPS Healthcare, the $10 billion business accounted for about one-tenth of UPS’ total revenue at the end of 2023. The company plans to double that figure by 2026 through acquisitions and new business ventures, like its latest undertaking, Labport.